COVID-19

In an open letter, the American Pharmacist Association’s (APhA) Board of Trustees called for Americans to continue following public health guidelines.

Unemployment rates compounded with high medical costs plague the diabetes community during the coronavirus disease 2019 (COVID-19) pandemic.

Several pharmacy organizations have stressed that the next coronavirus economic relief package should include provisions directed toward pharmacies.

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.

The American Pharmacists Association (APhA) urged Congress to take immediate action to expand coronavirus disease 2019 (COVID-19) testing services by granting pharmacists temporary provider status.

In this episode of Over the Counter, 2 experts on diabetes management and care discuss the effect COVID-19 is having on individuals with diabetes and the ways that the health care system is responding.

Here's this week's roundup of the coronavirus-related news you should know.

An inside look at the process from prescription to dispensing.

In a letter to President Trump, NCPA CEO explained that failure to implement sweeping DIR fee reform would be detrimental to independent community pharmacies and their patients.

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

The US government agreed to pay $1.95 billion for the first 100 million doses of Pfizer and BioNTech’s investigational candidate.

The Federal Vaccine Consultation Panel will allow industry leaders to share the questions, concerns, and needs of their constituencies related to the development and distribution planning of a COVID-19 vaccine.

Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.

Preparation taking place in some pharmacies, but clarification is still needed.

The AZD1222 vaccine, made from a common cold virus present in chimpanzees, produced rapid neutralizing antibody levels against the SARS-CoV-2 virus.

Here's the coronavirus-related news you should know from this week.

In episode 5 of Over the Counter, experts in technology and pharmacy highlight the major ways that telemedicine is rising to meet the COVID-19 pandemic.

Despite some anticipated hesitancy, demand for the novel coronavirus vaccine will be significant when it becomes available.

The campaign advocates for improvements to the next COVID-19 relief package, including expanded protections and roles for community pharmacists.

Pfizer and BioNTech SE announced that 2 of its most successful vaccine candidates received Fast Track designation from the FDA, opening the avenue for speedy development.

The therapy will also be available for individuals with asthma and suspected COVID-19 infection.

Moderna announced interim analysis results of its investigational COVID-19 vaccine candidate, mRNA-1273, from an ongoing phase 1 study.

Enhanced pharmacy services such as home delivery, curbside services, and expanded personal patient outreach create opportunities to address social determinants of health during the pandemic.

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.